ArticleCancer biology & therapy2019

Identification of a novel PDGFRA point mutation at p.P6L as a potential molecular target of imatinib in an eosinophilia patient showing genetic heterogeneity.

Miaomiao Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.